{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:22Z","timestamp":1786118782599,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/ftd.0b013e318067dfe7","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T00:34:53Z","timestamp":1180053293000},"page":"325-332","source":"Crossref","is-referenced-by-count":12,"title":["Highly Specific Quantification of Ergotamine in Urine, Blood, and Hair Samples by Liquid Chromatography-Tandem Mass Spectrometry"],"prefix":"10.1097","volume":"29","author":[{"given":"Donata","family":"Favretto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampietro","family":"Frison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Vogliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santo Davide","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(03)00439-3","article-title":"Convulsive ergotism: epidemics of the serotonin syndrome?","volume":"2","author":"Eadie","year":"2003","journal-title":"Lancet Neurol"},{"key":"R3-10-20210129","first-page":"190","article-title":"Kenntniss der Mutterkornalkaloide.","volume":"101","author":"Stoll","year":"1920","journal-title":"Veeh Dtsch Schweiz Naturf Ges"},{"key":"R4-10-20210129","first-page":"S15","article-title":"The pharmacology of ergotamine and dihydroergotamine.","volume":"37","author":"Silberstein","year":"1997","journal-title":"Headache"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1526-4610.2003.03034.x","article-title":"Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.","volume":"43","author":"Silberstein","year":"2003","journal-title":"Headache"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00605636","article-title":"Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.","volume":"16","author":"Ala-Hurula","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/clpt.1985.7","article-title":"Intramuscular ergotamine: plasma levels and dynamic activity.","volume":"37","author":"Tfelt-Hansen","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"R8-10-20210129","first-page":"476","article-title":"Ergotism with therapeutic doses of ergotamine tartrate.","volume":"89","author":"Matthews","year":"1979","journal-title":"N Z Med J"},{"key":"R9-10-20210129","first-page":"106","article-title":"Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man.","volume":"15","author":"Aellig","year":"1977","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00563557","article-title":"Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.","volume":"15","author":"Ala-Hurula","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1468-2982.1982.0203145.x","article-title":"Ergotamine in plasma and CSF after i.m. and rectal administration to humans.","volume":"2","author":"Hovdal","year":"1982","journal-title":"Cephalalgia"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00542326","article-title":"Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine.","volume":"21","author":"Ala-Hurula","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0047-0740(84)90040-8","article-title":"Immunoassay of ergotamine and dihydroergotamine using a common 3H-labelled ligand as tracer for specific antibody and means to overcome experienced pitfalls.","volume":"11","author":"Rosenthaler","year":"1984","journal-title":"Int J Nucl Med Biol"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0378-4347(00)84211-5","article-title":"Determination of ergot alkaloids in plasma by high-performance liquid chromatography and fluorescence detection.","volume":"226","author":"Edlund","year":"1981","journal-title":"J Chromatogr"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00547560","article-title":"Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers.","volume":"23","author":"Ibraheem","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00547370","article-title":"Linear pharmacokinetics of intravenous ergotamine tartrate.","volume":"29","author":"Ibraheem","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/bms.1200120503","article-title":"Measurement of ergotamine in human plasma by triple sector quadrupole mass spectrometry with negative ion chemical ionization.","volume":"12","author":"Haering","year":"1985","journal-title":"Biomed Mass Spectrom"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00541538","article-title":"Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.","volume":"30","author":"Sanders","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0378-4347(92)80159-N","article-title":"Identification and quantification of ergotamine in human plasma by gas chromatography-mass spectrometry.","volume":"575","author":"Feng","year":"1992","journal-title":"J Chromatogr"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0731-7085(94)80007-3","article-title":"Mass spectrometry as an aid to the identification of ergots and dihydroergots: comparison of hard and soft ionization techniques.","volume":"12","author":"Casy","year":"1994","journal-title":"J Pharm Biomed Anal"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.forsciint.2004.03.013","article-title":"A fatal overdose of the ergot derivative cabergoline.","volume":"146","author":"Johansen","year":"2004","journal-title":"Forensic Science Int"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jms.489","article-title":"High-sensitivity quantitation of cabergoline and pergolide using a triple-quadrupole mass spectrometer with enhanced mass-resolution capabilities.","volume":"38","author":"Hughes","year":"2003","journal-title":"J Mass Spectrom"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchromb.2004.03.049","article-title":"Determination of dihydroergocryptine in human plasma and urine samples using on-line sample extraction-column-switching reversed-phase liquid chromatography-mass spectrometry.","volume":"808","author":"Friedrich","year":"2004","journal-title":"J Chromatogr B"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1570-0232(03)00279-4","article-title":"Determination of cabergoline and L-dopa in human plasma using liquid chromatography-tandem mass spectrometry.","volume":"792","author":"Igarashi","year":"2003","journal-title":"J Chromatogr B"},{"key":"R25-10-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jchromb.2005.03.029","article-title":"Sensitive method for the quantitative determination of bromocriptine in human plasma by liquid chromatography-tandem mass spectrometry.","volume":"820","author":"Salvador","year":"2005","journal-title":"J Chromatogr B"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/jms.933","article-title":"Electrospray[+] tandem quadrupole mass spectrometry in the elucidation of ergot alkaloids chromatographed by HPLC: screening of grass or forage samples for novel toxic compounds.","volume":"40","author":"Lehner","year":"2005","journal-title":"J Mass Spectrom"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/jms.678","article-title":"Fragmentation patterns of selected ergot alkaloids by electrospray ionization tandem quadrupole mass spectrometry.","volume":"39","author":"Lehner","year":"2004","journal-title":"J Mass Spectrom"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/rcm.2648","article-title":"Mass spectral characterization of ergot alkaloids by electrospray ionization, hydrogen\/deuterium exchange, and tandem mass spectrometry: usefulness of precursor ion scan experiments.","volume":"20","author":"Mohamed","year":"2006","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R30-10-20210129","first-page":"51","article-title":"Spasm of arm arteries due to ergotamine tartrate: a case report.","volume":"10","author":"Palombo","year":"1991","journal-title":"Int Angiol"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0741-5214(86)90316-2","article-title":"Recognition and treatment of arterial insufficiency from cafergot.","volume":"4","author":"Wells","year":"1986","journal-title":"J Vasc Surg"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/096032718600500114","article-title":"Ergotamine-induced peripheral ischemia reversed by oral thymoxamine hydrochloride.","volume":"5","author":"Jones","year":"1986","journal-title":"Hum Toxicol"},{"key":"R33-10-20210129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0736-4679(01)00379-1","article-title":"An unusual case of clarithromycin associated ergotism.","volume":"21","author":"Ausband","year":"2001","journal-title":"J Emerg Med"},{"key":"R34-10-20210129","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/mas.20027","article-title":"Internal energy and fragmentation of ions produced in electrospray sources.","volume":"24","author":"Gabelica","year":"2005","journal-title":"Mass Spectrom Rev"},{"key":"R35-10-20210129","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/1096-9888(200007)35:7<804::AID-JMS22>3.0.CO;2-Q","article-title":"A brief overview of the present status of the mechanisms involved in electrospray mass spectrometry.","volume":"35","author":"Kebarle","year":"2000","journal-title":"J Mass Spectrom"},{"key":"R36-10-20210129","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1023\/A:1014050926916","article-title":"The chemistry of peptide ergot alkaloids. Part 1: classification and chemistry of ergot peptides.","volume":"35","author":"Komarova","year":"2001","journal-title":"Pharm Chem J"},{"key":"R37-10-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2006.02.019","article-title":"State of the art in hair analysis for detection of drug and alcohol abuse.","volume":"370","author":"Pragst","year":"2006","journal-title":"Clin Chim Acta"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e318067dfe7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:42:02Z","timestamp":1786034522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200706000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e318067dfe7","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}